Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70S6K in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 1, 2007, Pages 71-78

  Varma, Shailly ^a   Khandelwal, Ramji L ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Constitutively active Akt PKB; Human liver carcinoma cells; mTOR; p70S6k; Rapamycin

Indexed keywords

INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; RAPAMYCIN; S6 KINASE;

ARTICLE; CELL GROWTH; CELL STRAIN HEPG2; CELL SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE;

CELL LINE; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; PHOSPHORYLATION; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIROLIMUS;

MAMMALIA;

EID: 33845426904     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.07.016     Document Type: Article

References (35)

1. Jacinto E., and Hall M.N. Tor signalling in bugs, brain and brawn. Nat. Rev., Mol. Cell Biol. 4 (2003) 117-126
2. Schmelzle T., and Hall M.N. TOR, a central controller of cell growth. Cell 103 (2000) 253-262
3. Rohde J., Heitman J., and Cardenas M.E. The TOR kinases link nutrient sensing to cell growth. J. Biol. Chem. 276 (2001) 9583-9586
4. Mita M.M., Mita A., and Rowinsky E.K. Mammalian target of rapamycin: a new molecular target for breast cancer. Clin. Breast Cancer 4 (2003) 126-137
5. Xu X., Sakon M., Nagano H., Hiraoka N., Yamamoto H., Hayashi N., Dono K., Nakamori S., Umeshita K., Ito Y., Matsuura N., and Monden M. Akt2 expression correlates with prognosis of human hepatocellular carcinoma. Oncol. Rep. 11 (2004) 25-32
6. Isotani S., Hara K., Tokunaga C., Inoue H., Avruch J., and Yonezawa K. Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro. J. Biol. Chem. 274 (1999) 34493-34498
7. Hara K., Yonezawa K., Kozlowski M.T., Sugimoto T., Andrabi K., Weng Q.P., Kasuga M., Nishimoto I., and Avruch J. Regulation of eIF-4E BP1 phosphorylation by mTOR. J. Biol. Chem. 272 (1997) 26457-26463
8. Jefferies H.B., Fumagalli S., Dennis P.B., Reinhard C., Pearson R.B., and Thomas G. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J. 16 (1997) 3693-3704
9. Wu X., Reiter C.E., Antonetti D.A., Kimball S.R., Jefferson L.S., and Gardner T.W. Insulin promotes rat retinal neuronal cell survival in a p70S6K-dependent manner. J. Biol. Chem. 279 (2004) 9167-9175
10. Sehgal S.N., Baker H., and Vezina C. Rapamycin (AY-22, 989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J. Antibiot. 28 (1975) 727-732
11. Vignot S., Faivre S., Aguirre D., and Raymond E. mTOR-targeted therapy of cancer with rapamycin derivatives. Ann. Oncol. 16 (2005) 525-537
12. Raymond E., Alexandre J., Faivre S., Vera K., Materman E., Boni J., Leister C., Korth-Bradley J., Hanauske A., and Armand J.P. Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer. J. Clin. Oncol. 22 (2004) 2336-2347
13. Yu K., Toral-Barza L., Discafani C., Zhang W.G., Skotnicki J., Frost P., and Gibbons J.J. mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr. Relat. Cancer 8 (2001) 249-258
14. Pardee A.B. G1 events and regulation of cell proliferation. Science 246 (1989) 603-608
15. Gupta D., and Khandelwal R.L. Modulation of insulin effects on phosphorylation of protein kinase B and glycogen synthesis by tumor necrosis factor-alpha in HepG2 cells. Biochim. Biophys. Acta 1671 (2004) 51-58
16. Syed N.A., and Khandelwal R.L. Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells. Mol. Cell. Biochem. 211 (2000) 123-136
17. Kulik G., Klippel A., and Weber M.J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17 (1997) 1595-1606
18. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., and Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275 (1997) 661-665
19. Kauffmann-Zeh A., Rodriguez-Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J., and Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385 (1997) 544-548
20. Khamzina L., Veilleux A., Bergeron S., and Marette A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146 (2005) 1473-1481
21. Murakami M., Ichisaka T., Maeda M., Oshiro N., Hara K., Edenhofer F., Kiyama H., Yonezawa K., and Yamanaka S. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol. Cell. Biol. 24 (2004) 6710-6718
22. Seufferlein T., and Rozengurt E. Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells. Cancer Res. 56 (1996) 3895-3897
23. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology 24 (1992) 145-149
24. Sambrook J., Fritsch E.F., and Manniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
26. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferative and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
27. Bradford M.M. A rapid and sensitive for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
28. Gupta D., Syed N.A., Roesler W.J., and Khandelwal R.L. Effect of overexpression and nuclear translocation of constitutively active PKB-alpha on cellular survival and proliferation in HepG2 cells. J. Cell. Biochem. 93 (2004) 513-525
29. Scott P.H., Brunn G.J., Kohn A.D., Roth R.A., and Lawrence J.C. Jr., Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc. Natl. Acad. Sci. 95 (1998) 7772-7777
30. Shen W.H., Boyle D.W., Wisniowski P., Bade A., and Liechty E.A. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids. J. Endocrinol. 185 (2005) 275-289
31. Chung J., Grammer T.C., Lemon K.P., Kazlauskas A., and Blenis J. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370 (1994) 71-75
32. Shah O.J., Wang Z., and Hunter T. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr. Biol. 14 (2004) 1650-1656
33. Um S.H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P.R., Kozma S.C., Auwerx J., and Thomas G. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431 (2004) 200-205
34. Hosoi H., Dilling M.B., Shikata T., Liu L.N., Shu L., Ashmun R.A., Germain G.S., Abraham R.T., and Houghton P.J. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. Cancer Res. 59 (1999) 886-894
35. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101